Xxec, Inc. Laboratory Corp Of America Holdings Transaction History

Xxec, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$204.81 - $262.19 $42,805 - $54,797	-209 Reduced 2.19%	9,324 $1.91 Million
Q2 2022 Jul 26, 2022	SELL	$213.86 - $277.87 $15,184 - $19,728	-71 Reduced 0.74%	9,533 $2.23 Million
Q1 2022 Apr 12, 2022	SELL	$259.82 - $298.18 $32,737 - $37,570	-126 Reduced 1.29%	9,604 $2.61 Million
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $2.64 Million - $3.06 Million	9,730 New	9,730 $2.61 Million
Q3 2021 Oct 19, 2021	SELL	$274.82 - $308.34 $2.69 Million - $3.02 Million	-9,803 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$251.87 - $278.14 $49,618 - $54,793	-197 Reduced 1.97%	9,803 $2.7 Million
Q1 2021 Apr 16, 2021	BUY	$204.88 - $255.03 $2.05 Million - $2.55 Million	10,000 New	10,000 $2.55 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

Stay updated on Xxec, Inc. with notifications on news.